About ValueGene
ValueGene is a company based in San Diego (United States) founded in 2005 was acquired by Integrated DNA Technologies in June 2016. ValueGene operates in a competitive market with competitors including GenScript, Sino Biological, Miltenyi Biotec, Sebia and Devyser, among others.
- Headquarter San Diego, United States
- SectorsHealthcare
- Website valuegene.com
- Social LinkedIn Facebook
- Acquired by Integrated DNA Technologies (Jun 2016)
- Investors
- Acquired byIntegrated DNA Technologies
(Jun 2016)
Investors in ValueGene
ValueGene has secured backing from 1 investor. Prominent investors backing the company include Integrated DNA Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of oligonucleotide-based reagents and kits | 1987 | idtdna.com | Coralville, United States |
Investor details for ValueGene
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ValueGene
2 dated milestones of ValueGene across 11 years, from founding to its latest funding, stage changes and deals.
- Founded ValueGene is founded.
- Exit Acquired by Integrated DNA Technologies.
Competitors of ValueGene
ValueGene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Miltenyi Biotec, Sebia and Devyser, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15.0M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.4M | – | Reagents and kits are provided for clinical research applications. | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application | |
| sebia.com | 1967 | Evry Courcouronnes, France | – | – | Electrophoresis-based in vitro diagnostics products are developed and provided. | |
| devyser.com | 2004 | Stockholm, Sweden | $15.5M | – | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | |
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| exonhit.com | 1997 | Paris, France | $65.5M | – | Fully integrated in vitro diagnostics company specializing in transplantation, infectious diseases and cancer diagnosis | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. | |
| origene.com | 1996 | Rockville, United States | $69.6M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. |
Detailed competitors of ValueGene
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to ValueGene
10 companies that operate in the same segment as ValueGene (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ValueGene
ValueGene was founded in 2005.
ValueGene is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
ValueGene Inc. was founded in 2005 in San Diego, United States, as a biotech service company focused on gene discovery. Oligonucleotide synthesis services, including custom DNA and RNA production, are provided to biological research laboratories in academic institutions and biotech firms. The company was acquired by Integrated DNA Technologies in June 2016, expanding its operations within the sector.
ValueGene's top competitors include Sino Biological, BGI and GenScript.
ValueGene has 1 investor. Key investors include Integrated DNA Technologies.
Yes. ValueGene was acquired by Integrated DNA Technologies in June 2016.